These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28797568)

  • 41. Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells.
    Wang Y; Peng RQ; Li DD; Ding Y; Wu XQ; Zeng YX; Zhu XF; Zhang XS
    Chin J Cancer; 2011 Oct; 30(10):690-700. PubMed ID: 21959046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.
    Devy J; Wargnier R; Pluot M; Nabiev I; Sukhanova A
    Anticancer Res; 2004; 24(3a):1745-51. PubMed ID: 15274350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunodetection of human topoisomerase I-DNA covalent complexes.
    Patel AG; Flatten KS; Peterson KL; Beito TG; Schneider PA; Perkins AL; Harki DA; Kaufmann SH
    Nucleic Acids Res; 2016 Apr; 44(6):2816-26. PubMed ID: 26917015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mammalian DNA topoisomerase I mediates the enhancement of radiation cytotoxicity by camptothecin derivatives.
    Chen AY; Okunieff P; Pommier Y; Mitchell JB
    Cancer Res; 1997 Apr; 57(8):1529-36. PubMed ID: 9108456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.
    Hayashi S; Hatashita M; Matsumoto H; Shioura H; Kitai R; Kano E
    Int J Mol Med; 2006 Nov; 18(5):909-15. PubMed ID: 17016621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.
    Chen JH; Zhang P; Chen WD; Li DD; Wu XQ; Deng R; Jiao L; Li X; Ji J; Feng GK; Zeng YX; Jiang JW; Zhu XF
    Autophagy; 2015; 11(2):239-52. PubMed ID: 25701194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA topoisomerase I-targeting drugs as radiation sensitizers.
    Chen AY; Choy H; Rothenberg ML
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
    Sinha BK; van 't Erve TJ; Kumar A; Bortner CD; Motten AG; Mason RP
    Free Radic Biol Med; 2017 Dec; 113():406-412. PubMed ID: 29079526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
    Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.
    Ng B; Kramer E; Liebes L; Wasserheit C; Hochster H; Blank E; Ceriani R; Furmanski P
    Cancer Res; 2001 Apr; 61(7):2996-3001. PubMed ID: 11306478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
    Rowinsky EK; Adjei A; Donehower RC; Gore SD; Jones RJ; Burke PJ; Cheng YC; Grochow LB; Kaufmann SH
    J Clin Oncol; 1994 Oct; 12(10):2193-203. PubMed ID: 7931489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: a potential surrogate end point to assess treatment effectiveness.
    Whitacre CM; Zborowska E; Willson JK; Berger NA
    Clin Cancer Res; 1999 Mar; 5(3):665-72. PubMed ID: 10100720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
    Chen S; Gomez SP; McCarley D; Mainwaring MG
    Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro.
    Rave-Fränk M; Glomme S; Hertig J; Weiss E; Pradier O; Hess CF; Virsik-Köpp P; Schmidberger H
    Strahlenther Onkol; 2002 Sep; 178(9):497-503. PubMed ID: 12426836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro.
    Dalezis P; Geromichalos GD; Voyatzi S; Trafalis D; Athanassiou AE; Koutsilieris M; Papageorgiou A
    J BUON; 2006; 11(3):323-7. PubMed ID: 17309157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topotecan-loaded mesoporous silica nanoparticles for reversing multi-drug resistance by synergetic chemoradiotherapy.
    Shen B; Zhao K; Ma S; Yuan D; Bai Y
    Chem Asian J; 2015 Feb; 10(2):344-8. PubMed ID: 25413970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines.
    Taron M; Plasencia C; Abad A; Martin C; Guillot M
    Invest New Drugs; 2000 May; 18(2):139-47. PubMed ID: 10857993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.
    Jyoti A; Fugit KD; Sethi P; McGarry RC; Anderson BD; Upreti M
    Sci Rep; 2015 Oct; 5():15236. PubMed ID: 26468877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts.
    Serwer LP; Noble CO; Michaud K; Drummond DC; Kirpotin DB; Ozawa T; Prados MD; Park JW; James CD
    Neuro Oncol; 2011 Dec; 13(12):1288-95. PubMed ID: 21954443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.